# BIOGEN INC. (BIIB) FY2025 Annual Balance Sheet

- Company: BIOGEN INC. (BIIB)
- Period: As of 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-06, accession number 0000875045-26-000013
- Page: https://plicit.ai/financials/biib/fy2025-annual-balance-sheet
- Chart image: https://plicit.ai/charts/biib-fy2025-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 29,439,500,000 US dollars
- **Current assets**: 8,974,100,000 US dollars
- **Non-current assets**: 20,465,400,000 US dollars
- **Liabilities**: 11,182,700,000 US dollars
- **Current liabilities**: 3,349,400,000 US dollars
- **Non-current liabilities**: 7,833,300,000 US dollars
- **Equity**: 18,256,800,000 US dollars
- **Cash and cash equivalents**: 3,008,500,000 US dollars
- **Inventory**: 2,168,100,000 US dollars
- **Accounts receivable, net of allowance for doubtful accounts of $3.0 and $2.2, respectively**: 1,342,400,000 US dollars
- **Other current assets**: 1,123,300,000 US dollars
- **Current portion of marketable securities**: 807,200,000 US dollars
- **Due from anti-CD20 therapeutic programs**: 524,600,000 US dollars
- **Intangible assets, net**: 9,178,500,000 US dollars
- **Goodwill**: 6,491,100,000 US dollars
- **Property, plant and equipment, net**: 3,055,400,000 US dollars
- **Investments and other assets**: 750,600,000 US dollars
- **Marketable securities**: 431,900,000 US dollars
- **Deferred tax asset**: 292,500,000 US dollars
- **Operating lease assets**: 265,400,000 US dollars
- **Accrued expense and other**: 2,802,600,000 US dollars
- **Accounts payable**: 432,000,000 US dollars
- **Taxes payable**: 114,800,000 US dollars
- **Current portion of notes payable**: 0 US dollars
- **Notes payable**: 6,286,800,000 US dollars
- **Other long-term liabilities**: 748,500,000 US dollars
- **Deferred tax liability**: 507,600,000 US dollars
- **Long-term operating lease liabilities**: 290,400,000 US dollars
- **Retained earnings**: 20,552,700,000 US dollars
- **Additional paid-in capital**: 863,100,000 US dollars
- **Common stock, par value $0.0005 per share**: 100,000 US dollars
- **Preferred stock, par value $0.001 per share**: 0 US dollars
- **Treasury stock, at cost; 23.8 million and 23.8 million shares, respectively**: negative 2,977,100,000 US dollars
- **Accumulated other comprehensive income (loss)**: negative 182,000,000 US dollars
- **Gross equity (calculated)**: 21,415,900,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.